Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin E Karski

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Epidemiology|September 11, 2012
Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosisErin E Karski, Katherine K Matthay, John M Neuhaus, et al.
Journal of Pediatric Hematology/Oncology|March 1, 2014
Treatment of hepatoblastoma with high-dose chemotherapy and stem cell rescue: the pediatric blood and marrow transplant consortium experience and review of the literatureErin E Karski, Christopher C Dvorak, Wing Leung, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2017
Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After <sup>131</sup>I- Metaiodobenzylguanidine Therapy in Patients With NeuroblastomaKevin Campbell, Erin E Karski, Aleksandra Olow, et al.
Radiation Research|August 25, 2016
Transcript Analysis for Internal Biodosimetry Using Peripheral Blood from Neuroblastoma Patients Treated with (131)I-mIBG, a Targeted RadionuclideDavid A Edmondson, Erin E Karski, Ayano Kohlgruber, et al.
Oncotarget|October 30, 2016
Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumorsKieuhoa T Vo, Erin E Karski, Nicole M Nasholm, et al.
Pediatric Blood & Cancer|August 11, 2015
Identification of Discrete Prognostic Groups in Ewing SarcomaErin E Karski, Elizabeth McIlvaine, Mark R Segal, et al.
Nature Medicine|January 23, 2023
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim resultsSham Mailankody, Jeffrey V Matous, Saurabh Chhabra, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Epidemiology|September 11, 2012
Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosisErin E Karski, Katherine K Matthay, John M Neuhaus, et al.
Journal of Pediatric Hematology/Oncology|March 1, 2014
Treatment of hepatoblastoma with high-dose chemotherapy and stem cell rescue: the pediatric blood and marrow transplant consortium experience and review of the literatureErin E Karski, Christopher C Dvorak, Wing Leung, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2017
Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After <sup>131</sup>I- Metaiodobenzylguanidine Therapy in Patients With NeuroblastomaKevin Campbell, Erin E Karski, Aleksandra Olow, et al.
Radiation Research|August 25, 2016
Transcript Analysis for Internal Biodosimetry Using Peripheral Blood from Neuroblastoma Patients Treated with (131)I-mIBG, a Targeted RadionuclideDavid A Edmondson, Erin E Karski, Ayano Kohlgruber, et al.
Oncotarget|October 30, 2016
Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumorsKieuhoa T Vo, Erin E Karski, Nicole M Nasholm, et al.
Pediatric Blood & Cancer|August 11, 2015
Identification of Discrete Prognostic Groups in Ewing SarcomaErin E Karski, Elizabeth McIlvaine, Mark R Segal, et al.
Nature Medicine|January 23, 2023
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim resultsSham Mailankody, Jeffrey V Matous, Saurabh Chhabra, et al.
Pageof 1